Impact of Anti-Diabetic Medications on Quality of Life in Persons with Type 2 Diabetes Mellitus

Overview

Journal Indian J Endocrinol Metab

Specialty Endocrinology

Date 2022 Mar 18

PMID 35300440

Authors

Manash P Baruah

Ananya Bhowmick

Seema Bhuyan

Sonali B Bhuyan

Jumi Deka

Smriti Sikha Bora

Affiliations

Soon will be listed here.

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) has been found to be associated with poor quality of life (QOL). The aim of this study was to measure QOL in T2DM patients and examine if the patients' socio demographic, diabetes-related clinical characteristics and insulin usage are associated with better quality of life.

Materials And Methods: This clinic based cross-sectional study analyzed data from outpatients with T2DM attending a referral clinic between January and June 2016. Association between Diabetes Attitudes, Wishes and Needs (DAWN) QOL and few demographic, socioeconomic, clinical and biochemical predictors were examined using multivariate logistic regression model. A total of 518 patients completed the interview.

Results: The HbA1c level of insulin ± oral anti-diabetic (OAD) cohort was significantly lower (7.89 ± 1.98) than the OAD cohort (8.79 ± 1.96), < 0.001. Compared to their counterparts in the OAD cohort, patients on insulin were older with longer duration of diabetes mellitus. Co-morbid confounders like obesity, hypoglycemia, and blood pressure control or socio demographic confounders like income, education were almost similar in both the cohorts. The incidence of hypertension, coronary artery disease (CAD) and statin usage was significantly higher in the insulin cohort. The overall composite DAWN QOL scores of the insulin ± OAD cohort (25.42 ± 4.35) was marginally higher than that of the OAD cohort (23.62 ± 5.06) ( = 0.067). Analog insulin users were also found to have significantly higher composite DAWN QOL scores compared to human insulin users (25.77 ± 5.73 vs.24.13 ± 4.88, = 0.037).

Conclusions: The insulin cohort, despite being older and having longer duration of diabetes, had significantly higher diet compliance score, and enhanced QOL owing to better diabetes-related knowledge and treatment adherence characteristics than non-insulin users. Questionnaires-based evaluation of QOL can provide better understanding of the patient's experience of the illness, self-care, psychological and emotional functioning, and choice of therapeutic modality enhancing the quality of care.

Citing Articles

Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.

Emad-Eldin M, Balata G, Elshorbagy E, Hamed M, Attia M World J Diabetes. 2024; 15(5):828-852.

PMID: 38766443 PMC: 11099362. DOI: 10.4239/wjd.v15.i5.828.

The role of medication adherence in the association between depressive symptoms and quality of life in older adults with type 2 diabetes mellitus.

Yang H, Wu F, Gui M, Cheng Y, Zhang L BMC Geriatr. 2023; 23(1):196.

PMID: 36997851 PMC: 10064516. DOI: 10.1186/s12877-023-03929-8.

Quality of life and mental health measurements among patients with type 2 diabetes mellitus: a systematic review.

Alzahrani O, Fletcher J, Hitos K Health Qual Life Outcomes. 2023; 21(1):27.

PMID: 36949507 PMC: 10031182. DOI: 10.1186/s12955-023-02111-3.

Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system.

Mantri N, Merchant M, Rana J, Go A, Pursnani S BMC Cardiovasc Disord. 2022; 22(1):566.

PMID: 36564709 PMC: 9789536. DOI: 10.1186/s12872-022-02993-z.

References

Sehgal S, Khanolkar M . Starting insulin in type 2 diabetes: real-world outcomes after the first 12 months of insulin therapy in a new zealand cohort. Diabetes Ther. 2015; 6(1):49-60. PMC: 4374070. DOI: 10.1007/s13300-015-0100-8. View

Rosenblit P . Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?. Cardiovasc Diabetol. 2016; 15:95. PMC: 4946113. DOI: 10.1186/s12933-016-0412-7. View

Bahety P, Agarwal G, Khandelwal D, Dutta D, Kalra S, Taparia P . Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective. Indian J Endocrinol Metab. 2017; 21(4):564-569. PMC: 5477445. DOI: 10.4103/ijem.IJEM_123_17. View

Rubak S, Sandbaek A, Lauritzen T, Christensen B . Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005; 55(513):305-12. PMC: 1463134. View

Akinci F, Yildirim A, Gozu H, Sargin H, Orbay E, Sargin M . Assessment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey. Diabetes Res Clin Pract. 2007; 79(1):117-23. DOI: 10.1016/j.diabres.2007.07.003. View

Hanninen J, Takala J, Keinanen-Kiukaanniemi S . Good continuity of care may improve quality of life in Type 2 diabetes. Diabetes Res Clin Pract. 2001; 51(1):21-7. DOI: 10.1016/s0168-8227(00)00198-4. View

Skevington S, Lotfy M, OConnell K . The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004; 13(2):299-310. DOI: 10.1023/B:QURE.0000018486.91360.00. View

van Dam H, van der Horst F, van den Borne B, Ryckman R, Crebolder H . Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review. Patient Educ Couns. 2003; 51(1):17-28. DOI: 10.1016/s0738-3991(02)00122-2. View

Peyrot M, Burns K, Davies M, Forbes A, Hermanns N, Holt R . Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2013; 99(2):174-84. DOI: 10.1016/j.diabres.2012.11.016. View

10.

Gautam Y, Sharma A, Agarwal A, Bhatnagar M, Trehan R . A Cross-sectional Study of QOL of Diabetic Patients at Tertiary Care Hospitals in Delhi. Indian J Community Med. 2010; 34(4):346-50. PMC: 2822199. DOI: 10.4103/0970-0218.58397. View

11.

Daya R, Bayat Z, Raal F . Effects of diabetes mellitus on health-related quality of life at a tertiary hospital in South Africa: A cross-sectional study. S Afr Med J. 2016; 106(9):918-28. DOI: 10.7196/SAMJ.2016.v106i9.9899. View

12.

Houlden R, Ross S, Harris S, Yale J, Sauriol L, Gerstein H . Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study. Diabetes Res Clin Pract. 2007; 78(2):254-8. DOI: 10.1016/j.diabres.2007.03.021. View

13.

Lingvay I, Legendre J, Kaloyanova P, Zhang S, Adams-Huet B, Raskin P . Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?. Diabetes Care. 2009; 32(10):1789-95. PMC: 2752924. DOI: 10.2337/dc09-0653. View

14.

Barnard K, Skinner T, Peveler R . The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med. 2006; 23(4):445-8. DOI: 10.1111/j.1464-5491.2006.01814.x. View

15.

Hendrieckx C, De Smet F, Kristoffersen I, Bradley C . Risk assessment for developing type 1 diabetes: intentions of behavioural changes prior to risk notification. Diabetes Metab Res Rev. 2002; 18(1):36-42. DOI: 10.1002/dmrr.234. View

16.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

17.

Stuckey H, Vallis M, Burns K, Mullan-Jensen C, Reading J, Kalra S . "I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study). Clin Ther. 2015; 37(9):1986-1998.e12. DOI: 10.1016/j.clinthera.2015.06.010. View

18.

Auerbach S, Clore J, Kiesler D, Orr T, Pegg P, Quick B . Relation of diabetic patients' health-related control appraisals and physician-patient interpersonal impacts to patients' metabolic control and satisfaction with treatment. J Behav Med. 2002; 25(1):17-31. DOI: 10.1023/a:1013585617303. View

19.

. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998; 46(12):1569-85. DOI: 10.1016/s0277-9536(98)00009-4. View

20.

Jacobson A, Zevallos J, Smith M, Lazarus C, Husaini H, Okay D . Quality of life after management of advanced osteoradionecrosis of the mandible. Int J Oral Maxillofac Surg. 2013; 42(9):1121-8. DOI: 10.1016/j.ijom.2013.03.022. View